Tech Center 1600 • Art Units: 1612 1644 1656
This examiner grants 52% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17185196 | GENETICALLY MODIFIED BACTERIAL CELLS AND METHODS USEFUL FOR PRODUCING TETRAMETHYL PYRAZINE | Non-Final OA | The Regents of the University of California |
| 17795939 | COMPOSITIONS COMPRISING LINEAR POLYRIBONUCLEOTIDES FOR PROTEIN MODULATION AND USES THEREOF | Final Rejection | Flagship Pioneering Innovations VI, LLC |
| 18570018 | NONANIC ACID ESTERS | Non-Final OA | Evonik Operations GmbH |
| 18147630 | METHODS OF IMPROVING INTRACELLULAR BIOMOLECULE EXTRACTION YIELD AND METHODS OF CELL LYSIS | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 17258132 | NOVEL MICROORGANISMS FOR DECOMPOSING OIL AND FAT CONTAINING FATTY ACID | Non-Final OA | National University Corporation Tokai National Higher Education and Research System |
| 17437232 | MICROBIAL TEST KIT, MICROBIAL TEST METHOD AND MICROBIAL TEST DEVICE | Final Rejection | HITACHI HIGH-TECH CORPORATION |
| 17040448 | DEVICE FOR MANUFACTURING ORGANIC SUBSTANCE, AND GAS PROCESSING SYSTEM | Non-Final OA | SEKISUI CHEMICAL CO., LTD. |
| 18017479 | DNA-BINDING DOMAIN TRANSACTIVATORS AND USES THEREOF | Non-Final OA | University of Massachusetts |
| 17267816 | DESIGNED, EFFICIENT AND BROAD-SPECIFICITY ORGANOPHOSPHATE HYDROLASES | Final Rejection | Yeda Research and Development Co. Ltd. |
| 17292991 | MODULATION OF FORMATE OXIDATION BY RECOMBINANT YEAST HOST CELL DURING FERMENTATION | Final Rejection | DANSTAR FERMENT AG |
| 17299273 | Powder Detergent Compositions | Final Rejection | Novozymes A/S |
| 17974506 | COMPOSITIONS FOR INCREASING ETHANOL PRODUCTION AND RELATED METHODS | Final Rejection | KEMIN INDUSTRIES, INC. |
| 18691945 | A COMPOSITION FOR ANTI-BACTERIAL BIO-CELLULOSIC PATCHES USEFUL FOR TRANSDERMAL DRUG DELIVERY AND A PROCESS FOR THE PREPARATION THEREOF | Non-Final OA | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. |
| 18351069 | ENZYMATIC MODIFICATION OF PHOSPHOLIPIDS IN FOOD | Non-Final OA | DUPONT NUTRITION BIOSCIENCES APS |
| 18508933 | PRESSED AND MIXED THIN FILM ENZYMATIC REACTOR AND METHODS OF MAKING THE SAME | Non-Final OA | Waters Technologies Corporation |
| 17366443 | COMPOSITIONS, KITS AND METHODS USEFUL FOR SEPARATING PROTEINS FROM SURFACTANTS | Final Rejection | Waters Technologies Corporation |
| 18688983 | FUNGAL ENZYME MIXTURES AND USES THEREOF | Non-Final OA | Bio-Cat, Inc. |
| 18591010 | METHOD FOR THE ANALYSIS OF RELATED SUBSTANCES IN GERMINAL PEPTIDE PREPARATION | Non-Final OA | ZHAOKE (GUANGZHOU) OPHTHALMOLOGY PHARMACEUTICAL LIMITED |
| 18686731 | COLLAGEN BIOMATERIAL DERIVED FROM ABALONE | Non-Final OA | Bio Consultancy Pty Ltd |
| 17433971 | BIOMARKERS FOR DIAGNOSING OVARIAN CANCER | Final Rejection | Venn Biosciences Corporation |
| 18580308 | COMPOSITIONS AND METHODS FOR PRODUCTION OF VALUE-ADDED CHEMICALS | Non-Final OA | Solugen, Inc. |
| 18036538 | USE OF THERAPEUTIC ENZYME FUSION PROTEIN IN PREVENTION AND TREATMENT OF NEUROPATHY CAUSED BY OR ACCOMPANIED BY FABRY DISEASE | Non-Final OA | HANMI PHARM. CO., LTD. |
| 18036580 | USE OF THERAPEUTIC ENZYME FUSION PROTEIN IN PREVENTION AND TREATMENT OF RENAL DISEASES CAUSED BY OR ACCOMPANIED BY FABRY DISEASE | Non-Final OA | HANMI PHARM. CO., LTD. |
| 18572312 | MICROPARTICLE TISSUE SCAFFOLD COMPOSITIONS, APPARATUSES, METHODS OF PREPARATION, AND USES THEREOF | Non-Final OA | BIO-CHANGE LTD. |
| 18568728 | METHODS OF PROCESSING COLLAGEN FROM ANIMAL TISSUE | Non-Final OA | Grande Delta Corporation |
| 18332489 | LONG-ACTING RECOMBINANT INTERLEUKIN-18 BINDING PROTEIN AND PRODUCTION METHOD AND APPLICATION THEREOF | Non-Final OA | Guangdong Medical University |
| 18519523 | NOVEL ALDEHYDE DEHYDROGENASE FOOD AND DRUG COMPOSITION FOR IMPROVING BEHAVIOR AND MOTOR FUNCTION | Non-Final OA | PICOENTECH Co., LTD. |
| 18562048 | Chromogenic Absorbent Material for Animal Litter | Non-Final OA | 7905122 CANADA INC. |
| 18260225 | Methods and Compositions for Making Amide Compounds | Non-Final OA | Genomatica, Inc. |
| 17619554 | RECOMBINANT HUMAN COLLAGEN AND METHOD FOR BUILDING SAME | Final Rejection | NANTONG UNIVERSITY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy